Filing Details

Accession Number:
0000049071-19-000089
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-26 14:58:27
Reporting Period:
2019-08-22
Accepted Time:
2019-08-26 14:58:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
49071 Humana Inc HUM Hospital & Medical Service Plans (6324) 610647538
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1528285 P. Brian Leclaire Humana Inc.
500 West Main Street
Louisville KY 40202
Strategic Advisor No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Humana Common Acquisiton 2019-08-22 5,166 $217.42 12,994 No 4 M Direct
Humana Common Acquisiton 2019-08-22 2,073 $268.47 15,067 No 4 M Direct
Humana Common Disposition 2019-08-22 7,239 $289.70 7,828 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Humana Common Options Disposition 2019-08-22 5,166 $0.00 5,166 $217.42
Humana Common Options Disposition 2019-08-22 2,073 $0.00 2,073 $268.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,916 2024-03-08 No 4 M Direct
4,148 2025-02-19 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Humana Common 136 Indirect (See Footnote)
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Humana Common Options $307.97 2026-02-25 5,568 5,568 Direct
Humana Common Restricted Stock Units $0.00 2,971 2,971 Direct
Humana Common Restricted Stock Units $0.00 963 963 Direct
Humana Common Restricted Stock Units $0.00 1,258 1,258 Direct
Humana Common Phantom Stock Units $0.00 62 62 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-02-25 5,568 5,568 Direct
2,971 2,971 Direct
963 963 Direct
1,258 1,258 Direct
62 62 Indirect
Footnotes
  1. Stock units held for the benefit of reporting person as of July 31, 2019 under the Humana Retirement & Savings Plan including a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, both exempt under Rule 16b-3(c).
  2. Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant.
  3. Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/18, vesting in three increments from 02/19/19 to 02/19/21.
  4. Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/19, vesting in three increments from 02/25/20 to 02/25/22.
  5. Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
  6. Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments on 12/15/17, 12/15/18, and 12/15/19. 1,782 shares fully vest three years from the date of grant.
  7. Restricted stock units granted to reporting person on 02/19/18, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20.
  8. Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21.
  9. Phantom Stock Units held for the benefit of reporting person as of July 31, 2019 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctation due to changes in stock price.
  10. Shares sold at prices ranging from $288.86 to $291.18. Price reported is weighted average sales price.